Ampholytic Carbon Dots Enable Imaging and Modulation of Amyloid Fibrillation with Reduced Neurotoxicity
Source abstract
Abstract
Neurodegenerative diseases like Alzheimer's are driven by protein aggregation, notably amyloid-β (Aβ) fibrillation and associated cytotoxicity. Here, we report the design of ampholytic carbon dots (ACDs) with red/green emission that bind/control amyloid fibrillation. These ACDs bind with amyloid structures via electrostatic and van der Waals interactions and effectively inhibit fibril formation as well as promote disintegration of mature fibrils. The fluorescence property of ACDs enable high-resolution fluorescence imaging of amyloid structures at intra/extracellular space. ACD-amyloid conjugates showed lysosomal entrapment with lower amyloid-induced cytotoxicity via the lowering of reactive oxygen species generation. Together, these results highlight the dual functionality of ACDs as imaging and antiamyloidogenic agents, offering a promising nanoplatform for the diagnosis and treatment of amyloid-associated neurodegenerative disorders.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Alzheimer's disease research and treatments · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Materials Science, Indian Association for the Cultivation of Science, 2A and 2B Raja S C Mullik Road, Kolkata 700032, India
Funding
Science and Engineering Research Board
References (38)
Show source-provided references
1. 10.1126/science.106712210.1126/science.1067122 ↗
2. 10.1038/s41593-018-0235-910.1038/s41593-018-0235-9 ↗
3. 10.1126/science.107299410.1126/science.1072994 ↗
4. 10.3390/ijms23211292410.3390/ijms232112924 ↗
5. 10.7150/ijbs.5707810.7150/ijbs.57078 ↗
6. 10.14336/AD.2021.071910.14336/AD.2021.0719 ↗
7. 10.1038/nature1932310.1038/nature19323 ↗
8. 10.1021/jacsau.5c0000210.1021/jacsau.5c00002 ↗
9. 10.1021/acsomega.4c0177410.1021/acsomega.4c01774 ↗
10. 10.1021/acsomega.4c0552710.1021/acsomega.4c05527 ↗
11. 10.1021/acsnano.3c0882310.1021/acsnano.3c08823 ↗
12. 10.1021/acsnano.4c1196610.1021/acsnano.4c11966 ↗
13. 10.1021/acschemneuro.1c0003510.1021/acschemneuro.1c00035 ↗
14. 10.1021/cn300196n10.1021/cn300196n ↗
15. 10.1021/jacs.2c1221410.1021/jacs.2c12214 ↗
16. 10.1021/acs.nanolett.8b0364410.1021/acs.nanolett.8b03644 ↗
17. 10.1021/acs.biomac.8b0067110.1021/acs.biomac.8b00671 ↗
18. 10.1021/acs.biomac.0c0071310.1021/acs.biomac.0c00713 ↗
19. 10.1021/acs.biomac.0c0014310.1021/acs.biomac.0c00143 ↗
20. 10.1021/acs.langmuir.7b0220210.1021/acs.langmuir.7b02202 ↗
21. 10.1021/acsami.6b0685310.1021/acsami.6b06853 ↗
22. 10.1021/acsami.7b0651010.1021/acsami.7b06510 ↗
23. 10.1002/smsc.20220001210.1002/smsc.202200012 ↗
24. 10.2147/IJN.S38803010.2147/IJN.S388030 ↗
25. 10.1021/acsami.4c0160910.1021/acsami.4c01609 ↗
26. 10.1021/ja904843x10.1021/ja904843x ↗
27. 10.1021/acsami.5b1131810.1021/acsami.5b11318 ↗
28. 10.1021/acsanm.0c0279210.1021/acsanm.0c02792 ↗
29. 10.1021/acssuschemeng.9b0271010.1021/acssuschemeng.9b02710 ↗
30. 10.1155/2017/702973110.1155/2017/7029731 ↗
31. 10.1038/s41586-024-07326-y10.1038/s41586-024-07326-y ↗
32. 10.1016/j.addr.2019.04.00810.1016/j.addr.2019.04.008 ↗
33. 10.1110/ps.0318340410.1110/ps.03183404 ↗
34. 10.1111/j.1742-4658.2009.07307.x10.1111/j.1742-4658.2009.07307.x ↗
35. 10.1021/acsami.4c1633710.1021/acsami.4c16337 ↗
36. 10.1002/ana.2000910.1002/ana.20009 ↗
37. 10.1016/j.jcis.2024.05.07210.1016/j.jcis.2024.05.072 ↗
38. 10.1039/D4TB02104E10.1039/D4TB02104E ↗